New Lyme vaccine faces skepticism from high-risk hunters

KFF Health News found that a new Lyme disease vaccine developed for humans, despite being crucial for high-exposure groups, faces resistance from hunters. This group, often conservative, rural, and male, represents a demographic with historically higher vaccine hesitancy, even though they spend more time outdoors — and are more at risk for tick-borne diseases.